Tumor Suppression by ARF in Carcinogen-Exposed Mice

ResearchWorks/Manakin Repository

Search ResearchWorks

Advanced Search


My Account


Related Information

Tumor Suppression by ARF in Carcinogen-Exposed Mice

Show full item record

Title: Tumor Suppression by ARF in Carcinogen-Exposed Mice
Author: Busch, Stephanie E.
Abstract: The <italic>ARF</italic> tumor suppressor gene, encoded along with a second tumor suppressor, <italic>p16INK4a</italic>, at the <italic>CDKN2A</italic> locus, is frequently inactivated in human cancers. However, the close proximity of <italic>ARF</italic> and <italic>p16INK4a</italic> lends itself to the concurrent loss of both genes, raising important questions about the specific contribution of ARF to tumor suppression <italic>in vivo</italic>. Multiple lines of evidence indicate that sustained signaling from oncogenes such as RAS or MYC induces the expression of ARF, which then stabilizes p53 activity to arrest cell proliferation. To address the role of ARF in RAS-driven cancers, we exposed wild-type and <italic>Arf</italic>-deficient mice to two separate carcinogens, ethyl carbamate (urethane) and 7,12-dimethylbenz[a]anthracene (DMBA). <italic>Arf</italic>-deficiency facilitated the growth and malignant progression of lung adenocarcinomas after urethane exposure. A subset of lung tumors in <italic>Arf</italic>-deficient animals presented as poorly differentiated and metastatic, with many characteristics of pulmonary sarcomatoid carcinoma, a transitional tumor type previously undocumented in mice. Unexpectedly, urethane injection also resulted in the development of hepatic vascular tumors in <italic>Arf</italic>-deficient animals. Suppression of hemangioma development by ARF was strongly influenced by mouse genetic strain and was likely p53-dependent. Subjection of mice to the DMBA/TPA two-step skin carcinogenesis protocol further revealed that ARF inhibits the metastatic spread of carcinoma cells. The pro-invasion and metastasis phenotype of <italic>Arf</italic>-deficient carcinomas was apparent at the transcriptional level, and our data provide preliminary evidence of a role for ARF in regulating the epithelial-mesenchymal transition program. Taken together, these studies demonstrate that induction of ARF is an early response in carcinogenesis that mounts an effective barrier against tumor growth, invasion, and metastasis. For this reason, <italic>ARF</italic> status may have important implications for cancer patient prognosis and clinical management.
Description: Thesis (Ph.D.)--University of Washington, 2012
URI: http://hdl.handle.net/1773/20773
Author requested restriction: Restrict to UW for 2 years -- then make Open Access
Date available: 2014-09-03

Files in this item

Files Size Format View
Busch_washington_0250E_10619.pdf 53.11Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record